Six hundred fifty-five patients underwent surgical treatment for hemorrhoids at our institution during the study period.
Three hundred sixty-two patients (55.2%) agreed to participate and were included in the study, of whom 215 underwent SH, 99 underwent EH, and 48 underwent a combined procedure.
One hundred forty-two (39.2%) patients were female, patients ages ranged from 22 to 88 years; the median overall follow-up time was 45.8 months (ranged between 19.5 to 86.4 months). There were no differences between the three groups regarding sex, age, type of anesthesia, American Society of Anesthesiology (ASA) score, comorbidities, and previous interventions for hemorrhoids (Table 1). Twenty-seven patients (7.5%) underwent previous interventions for hemorrhoids, either clinic-based procedures or surgery; there was no difference between the groups regarding previous intervention for symptomatic hemorrhoids (p = 0.229) (Table 2).
Follow-up time from surgery to questionnaire was longer for patient who underwent SH as compared to that of patients who had EH or combined procedures (49 months, 41 months and 43 months respectively, p = 0.02).
Table 1
Comparing patients’ demographic and clinical characteristics between the three groups.
|
|
SH
|
EH
|
combined surgery
|
p.value
|
No. of patients
|
|
215
|
99
|
48
|
|
Age (SD)
|
|
52.30 (15.40)
|
49.42 (13.27)
|
51.46 (15.50)
|
0.282
|
Sex N(%)
|
male
|
126 (58.6)
|
69 ( 69.7)
|
25 ( 52.1)
|
0.072
|
female
|
89 (41.4)
|
30 ( 30.3)
|
23 ( 47.9)
|
Types of anesthesia
N(%)
|
General
|
127 (59.9)
|
70 ( 70.7)
|
33 ( 68.8)
|
0.139
|
Spinal
|
85 (40.1)
|
29 ( 29.3)
|
15 ( 31.2)
|
ASA score N(%)
|
1
|
87 (50.3)
|
27 ( 33.3)
|
16 ( 39.0)
|
0.248
|
2
|
74 (42.8)
|
47 ( 58.0)
|
23 ( 56.1)
|
3
|
10 ( 5.8)
|
6 ( 7.4)
|
2 ( 4.9)
|
4
|
2 ( 1.2)
|
1 ( 1.2)
|
0 ( 0.0)
|
Received anticoagulants N(%)
|
No
|
191 (88.8)
|
90 ( 90.9)
|
44 ( 91.7)
|
0.766
|
Yes
|
24 (11.2)
|
9 ( 9.1)
|
4 ( 8.3)
|
CHF N(%)
|
No
|
213 (99.1)
|
97 ( 98.0)
|
46 ( 95.8)
|
0.268
|
Yes
|
2 ( 0.9)
|
2 ( 2.0)
|
2 ( 4.2)
|
Chronic lung disease N(%)
|
No
|
209 (97.2)
|
94 ( 94.9)
|
46 ( 95.8)
|
0.591
|
Yes
|
6 ( 2.8)
|
5 ( 5.1)
|
2 ( 4.2)
|
CRF N(%)
|
No
|
214 (99.5)
|
98 ( 99.0)
|
47 ( 97.9)
|
0.521
|
Yes
|
1 ( 0.5)
|
1 ( 1.0)
|
1 ( 2.1)
|
CVA N(%)
|
No
|
210 (97.7)
|
94 ( 95.9)
|
48 (100.0)
|
0.322
|
Yes
|
5 ( 2.3)
|
4 ( 4.1)
|
0 ( 0.0)
|
Other neurological conditions N(%)
|
No
|
207 (96.3)
|
96 ( 98.0)
|
47 ( 97.9)
|
0.665
|
Yes
|
8 ( 3.7)
|
2 ( 2.0)
|
1 ( 2.1)
|
DM N(%)
|
No
|
197 (91.6)
|
90 ( 90.9)
|
46 ( 95.8)
|
0.561
|
Yes
|
18 ( 8.4)
|
9 ( 9.1)
|
2 ( 4.2)
|
HTN N(%)
|
No
|
173 (80.5)
|
83 ( 83.8)
|
39 ( 81.2)
|
0.774
|
Yes
|
42 (19.5)
|
16 ( 16.2)
|
9 ( 18.8)
|
IHD N(%)
|
No
|
204 (94.9)
|
96 ( 97.0)
|
46 ( 95.8)
|
0.702
|
Yes
|
11 ( 5.1)
|
3 ( 3.0)
|
2 ( 4.2)
|
Immunosuppression status N(%)
|
No
|
212 (98.6)
|
99 (100.0)
|
48 (100.0)
|
0.356
|
Yes
|
3 ( 1.4)
|
0 ( 0.0)
|
0 ( 0.0)
|
Follow up (months) IQR
|
|
49.07 [36.37, 68.20]
|
41.43 [30.85, 59.77]
|
43.17 [31.09, 61.69]
|
0.02
|
SH- stapled hemorrhoidectomy, EH- excisional hemorrhoidectomy,
ASA- American Society of Anesthesiology) score, CHF- congestive heart failure, CRF- chronic renal failure, CVA-cerebrovascular accident, DM-diabetic Mellitus, HTN-hypertension, IHD-ischemic heart disease., IQR-inter-quartile range
Table 2
Previous interventions for symptomatic hemorrhoids.
|
SH (n = 215)
|
EH (n = 99)
|
Combined procedures (n = 48)
|
P. value
|
Any intervention N(%)
|
14 (6.5)
|
11 (11.1)
|
2 (4.2)
|
0.229
|
Rubber band ligation N(%)
|
5 (0.023)
|
2 (0.02)
|
0 (0)
|
|
HAL N(%)
|
1 (0.0046)
|
0 (0)
|
0 (0)
|
|
SH N(%)
|
2 (0.009)
|
4 (0.04)
|
1 (0.02)
|
|
EH N(%)
|
2 (0.009)
|
4 (0.04)
|
1 (0.02)
|
|
Unknown procedure N(%)
|
4 (0.018)
|
0 (0)
|
0 (0)
|
|
SH-stapled hemorrhoidopexy, EH -excisional hemorroidectomy, CS combined surgery, HAL- Hemorrhoidal artery ligation.
Operative and postoperative complications
Twenty-three patients (6.3%) experienced postoperative complications or readmissions. Five patients required a blood transfusion, five had urinary retention, and seven were readmitted for pain control. One patient had retroperitoneal bleeding caused by a pudendal block performed at the time of surgery. Two patients underwent emergency re-intervention: one due to bleeding and one due to an abscess. One patient was admitted to the neurology department for post–spinal anesthesia headache, one had a long admission for postoperative diabetic control, and one suffered a stapler line perforation after using an enema. There was no difference between the groups in complication rate (p = 0.074, Table 3).
Table 3
post-operative complications
|
SH (n = 215)
|
EH (n = 99)
|
CS (n = 48)
|
P. value
|
Any complications
|
10 (4.7)
|
11 (11.1)
|
2(4.2)
|
0.074
|
Bleeding requiring blood transfusion N(%)
|
3 (0.01)
|
1 (0.01)
|
1 (0.02)
|
|
Reoperation N(%)
|
2 (0.009)
|
0 (0)
|
0 (0)
|
|
Urinary retention N(%)
|
1 (0.004)
|
4 (0.04)
|
0 (0)
|
|
Other major complication # N(%)
|
2 (0.009)
|
0 (0)
|
0 (0)
|
|
Readmission for pain N(%)
|
1(0.004)
|
5 (0.05)
|
1 (0.02)
|
|
Non-perianal related admission* N (%)
|
1 (0.004)
|
1 (0.01)
|
0 (0)
|
|
SH- stapled hemorrhoidopexy, EH- excisional hemorrhoidectomy, CS-combined surgery.
# Retroperitoneal bleeding, stapler line perforation due to enema
*Diabetes mellitus control, post spinal-anesthesia headache.
Recurrent symptoms and fecal incontinence
One hundred ninety-six patients (54.1%) reported symptoms that might be attributed to recurrent disease; eighty patients reported itching, 117 (32.3%) reported bleeding, 130 (35.9%) reported pain, and 142 (39.2%) reported perianal swelling. However, only 90 patients (24.8%) required symptomatic treatment of some sort and only 19 (5.2%) were definitely diagnosed with recurrent symptomatic hemorrhoids and required repeated interventions for recurrent symptoms.
Two hundred and seventy-seven patients (76.5%) reported perfect continence (FIS = 0). Only 22 patients (6.1%) had a FIS ≥ 10. Only one patient reported deterioration in his incontinence status following the surgery. No statistically significant differences between the groups were found regarding FIS or symptoms' recurrence (Table 4).
Table 4
Comparing outcomes between the three groups.
Factor
|
Group
|
SH
|
EH
|
combined
|
p.value
|
No.
|
|
215
|
99
|
48
|
|
Symptoms that might be attributed to recurrent disease:
|
Reported any symptoms that might be attributed to recurrent disease N(%)
|
|
118 (54.9)
|
56 (56.6)
|
22 (45.8)
|
0.446
|
Pain, N(%)
|
No
|
138 (64.2)
|
61 (61.6)
|
33 (68.8)
|
0.699
|
Yes
|
77 (35.8)
|
38 (38.4)
|
15 (31.2)
|
Itching, N(%)
|
No
|
168 (78.1)
|
74 (74.7)
|
40 (83.3)
|
0.496
|
Yes
|
47 (21.9)
|
25 (25.3)
|
8 (16.7)
|
Swelling, N(%)
|
No
|
126 (58.6)
|
61 (61.6)
|
33 (68.8)
|
0.42
|
Yes
|
89 (41.4)
|
38 (38.4)
|
15 (31.2)
|
Bleeding, N(%)
|
No
|
143 (66.5)
|
68 (68.7)
|
34 (70.8)
|
0.819
|
Yes
|
72 (33.5)
|
31 (31.3)
|
14 (29.2)
|
Needed any treatment for anorectal symptoms?, N(%)
|
No
|
143 (66.8)
|
71 (71.7)
|
38 (79.2)
|
0.244
|
Symptomatic conservative treatment
|
56 (26.2)
|
24 (24.2)
|
10 (20.8)
|
Interventional treatment
|
15 ( 7.0)
|
4 ( 4.0)
|
0 ( 0.0)
|
Fecal incontinence score:
|
Gas incontinence, N(%)
|
0
|
165 (77.5)
|
84 (86.6)
|
42 (87.5)
|
0.104
|
1
|
1 ( 0.5)
|
2 ( 2.1)
|
2 ( 4.2)
|
2
|
5 ( 2.3)
|
1 ( 1.0)
|
1 ( 2.1)
|
3
|
13 ( 6.1)
|
3 ( 3.1)
|
0 ( 0.0)
|
4
|
29 (13.6)
|
7 ( 7.2)
|
3 ( 6.2)
|
Liquid incontinence, N(%)
|
0
|
190 (88.8)
|
84 (86.6)
|
45 (93.8)
|
0.876
|
1
|
6 ( 2.8)
|
3 ( 3.1)
|
0 ( 0.0)
|
2
|
6 ( 2.8)
|
3 ( 3.1)
|
1 ( 2.1)
|
3
|
3 ( 1.4)
|
3 ( 3.1)
|
0 ( 0.0)
|
4
|
9 ( 4.2)
|
4 ( 4.1)
|
2 ( 4.2)
|
Solid incontinence, N(%)
|
0
|
192 (89.7)
|
90 (92.8)
|
45 (93.8)
|
0.551
|
1
|
8 ( 3.7)
|
2 ( 2.1)
|
0 ( 0.0)
|
2
|
3 ( 1.4)
|
0 ( 0.0)
|
0 ( 0.0)
|
3
|
3 ( 1.4)
|
1 ( 1.0)
|
2 ( 4.2)
|
4
|
8 ( 3.7)
|
4 ( 4.1)
|
1 ( 2.1)
|
Wearing pads, N(%)
|
0
|
202 (94.4)
|
94 (96.9)
|
47 (97.9)
|
0.825
|
1
|
2 ( 0.9)
|
0 ( 0.0)
|
0 ( 0.0)
|
2
|
1 ( 0.5)
|
1 ( 1.0)
|
0 ( 0.0)
|
3
|
3 ( 1.4)
|
0 ( 0.0)
|
0 ( 0.0)
|
4
|
6 ( 2.8)
|
2 ( 2.1)
|
1 ( 2.1)
|
Lifestyle alternation, N(%)
|
0
|
191 (89.3)
|
91 (93.8)
|
45 (93.8)
|
0.8
|
1
|
7 ( 3.3)
|
1 ( 1.0)
|
0 ( 0.0)
|
2
|
1 ( 0.5)
|
1 ( 1.0)
|
0 ( 0.0)
|
3
|
4 ( 1.9)
|
1 ( 1.0)
|
1 ( 2.1)
|
4
|
11 ( 5.1)
|
3 ( 3.1)
|
2 ( 4.2)
|
FIS, median (IQR)
|
|
0.00 [0.00, 1.00]
|
0.00 [0.00, 0.00]
|
0.00 [0.00, .00]
|
0.096
|
SH-Stapled hemorrhoidopexy, EH- excisional hemorrhoidectomy. IQR-inter-quartile range |
Patient satisfaction
One hundred fifty-eight of the patients who underwent SH (79%), 57 of the patients who underwent EH (67.9%) and 36 of the patients who underwent combined procedures (80%) stated they would undergo surgery again if needed (p = 0.108).
A multivariate logistic regression model was utilized to assess factors affecting satisfaction. Symptoms that might be attributed to recurrent disease and female gender both had a significantly negative effect on patient satisfaction (p < 0.001, p = 0.002, respectively). The surgical technique did not affect patient satisfaction (p = 0.966).
There was no significant difference between the three groups while comparing the improvement in quality of life (p = 0.111).
While comparing only EH to SH, the difference in patient satisfaction rate between the groups became statistically significant (p = 0.011, Table 5). More patients in the SH group stated they would undergo the surgery again if needed (Fig. 1). However, no difference in the self-assessed quality of life improvement was found (Table 5, p = 0.904)
Table 5
comparing patient satisfaction between EH and SH groups.
|
SH
N = 215
|
EH
N = 99
|
P value.
|
Would you undergo the surgery again if needed
|
No
|
42 (19.5)
|
27 (27.3)
|
0.011
|
Yes
|
158 (73.5)
|
57 (57.6)
|
Maybe
|
15 (7.0)
|
15 (15.2)
|
Improvement in QOL, median (IQR)
|
|
8.00 [5.00, 10.00]
|
8.00 [6.00, 10.00]
|
0.903
|
Fecal incontinence score, median (IQR)
|
|
0.00 [0.00, 1.00]
|
0.00 [0.00, 0.00]
|
0.106
|
SH-Stapled hemorrhoidopexy, EH-Excisional hemorrhoidectomy, IQR-inter-quartile range.